Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | KDM4A | O75164 | 11/20 | 0.52 |
| ▸ | KDM4C | Q9H3R0 | 11/20 | 0.52 |
| ▸ | KDM5A | P29375 | 2/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.52 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.52 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.52 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18556504 | 1.00 | TSHR (0.58) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL10084980 | 0.98 | TSHR (0.61) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL713902 | 0.91 | TSHR (0.64) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL25181649 | 0.90 | TSHR (0.52) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL16644552 | 0.89 | DNM1 (0.60) | TSHRMEN1KMT2AALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL1671482 | 0.89 | MEN1 (0.61) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL18499076 | 0.87 | KMT2A (0.65) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL15155313 | 0.85 | TSHR (0.42) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL15155984 | 0.85 | TSHR (0.42) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL15155559 | 0.85 | TSHR (0.42) | TSHRMEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3608308-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2020-02-12 | — | — | EP | disclosed |
| US-8436138-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2013-05-07 | — | — | US | disclosed |
| US-8436138-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2013-05-07 | — | — | US | disclosed |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2012-03-01 | — | — | US | disclosed |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2012-03-01 | — | — | US | disclosed |
| US-8017347-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2011-09-13 | — | — | US | disclosed |
| US-8017347-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2011-09-13 | — | — | US | disclosed |
| US-20090305298-A1 | Binder for C-Reactive Protein | MODPRO AB (SE) | 2009-12-10 | — | — | US | disclosed |
| US-20090305298-A1 | Binder for C-Reactive Protein | MODPRO AB (SE) | 2009-12-10 | — | — | US | disclosed |
| EP-2007801-A1 | BINDER FOR C-REACTIVE PROTEIN | Modpro AB (SE) | 2008-12-31 | — | — | EP | disclosed |
| US-5580481-A | Aqueous fabric softener composition, novel quaternary ammonium salt, and process for the preparation of said salt | KAO CORPORATION (JP) | 1996-12-03 | — | — | US | disclosed |
| US-5476597-A | Storage stability, elasticity | KAO CORPORATION (JP) | 1995-12-19 | — | — | US | disclosed |
| EP-0643128-A1 | Aqueous fabric softener composition, novel quaternary ammonium salt, and process for the preparation of said salt | Kao Corporation (JP) | 1995-03-15 | — | — | EP | disclosed |
| EP-0014402-B1 | NOVEL 20-0-ACYLMAYTANSINOIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Takeda Chemical Industries, Ltd. (JP) | 1983-07-20 | — | — | EP | disclosed |
| US-4361650-A | BACILLUS, STREPTOMYCES OR ACTINOMYCES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-11-30 | — | — | US | disclosed |
| EP-0004466-B1 | DEMETHYL MAYTANSINOIDS AND METHODS FOR PRODUCING THEM | Takeda Chemical Industries, Ltd. (JP) | 1982-01-27 | — | — | EP | disclosed |
| US-4307016-A | FUNGICIDES, PROTOZOACIDES OR ANTITUMOR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4294757-A | BLEACHING CELLULOSE FIBERS AND ADDITION OF ALKALI METAL POLYPHOSPHATES AND ALKALI METAL DIETHYLENETRIAMINE PENTA(METHYLENE PHOSPHONAT) | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 1981-10-13 | — | — | US | disclosed |
| EP-0014402-A1 | Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1980-08-20 | — | — | EP | disclosed |
| EP-0004466-A1 | Demethyl maytansinoids and methods for producing them | Takeda Chemical Industries, Ltd. (JP) | 1979-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305298-A1 | Binder for C-Reactive Protein | C1QBP, RBP1, MYCBP | TSHR 3024/4885MEN1 3683/4885KMT2A 2792/4885 |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | C1QBP, RBP1, MYCBP | TSHR 3024/4885MEN1 3683/4885KMT2A 2792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.